Limited data about New Delhi metallo-β-lactamase (NDM) bacteremia are available. Blood isolates from 40 patients with NDM bacteremia were studied for antibiotic susceptibility and whole-genomic sequencing. NDM bacteremia has high 30-day mortality. In most cases, aztreonam-avibactam is active in vitro. Ceftazidime-avibactam plus aztreonam may represent a feasible therapeutic option.
Keywords: New Delhi metallo-β-lactamases; bacteremia; carbapenem-resistant.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.